PROCEDURES FOR THE INACTIVATION OF VIRUSES IN CLOTTING FACTOR CONCENTRATES

[1] ALLAIN JP, 1984, SCAND J HAEMATOL S, V41, P173

[2] ARONSON DL, 82196 TRAV LAB HYL T

[3] ARONSON DL, 84069 ALPH THER CORP

[4] ARONSON DL, 83367 ARM PHARM CO R

[5] ARONSON DL, 83341 MIL LAB REF

[6] CARNELLI V, COMMUNICATION

[7] CARNELLI V, 1986, 17 INT C WORLD FED H

[8] ANALYSIS OF CYTOMEGALOVIRUS AND EPSTEIN-BARR VIRUS-ANTIBODY RESPONSES IN TREATED HEMOPHILIACS - IMPLICATIONS FOR THE STUDY OF ACQUIRED IMMUNE-DEFICIENCY SYNDROME [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 252 (01): : 83 - 85

[9] COLOMBO M, 1985, LANCET, V2, P1

[10] EIBL H, COMMUNICATION

[1] ALLAIN JP, 1984, SCAND J HAEMATOL S, V41, P173

[2] ARONSON DL, 82196 TRAV LAB HYL T

[3] ARONSON DL, 84069 ALPH THER CORP

[4] ARONSON DL, 83367 ARM PHARM CO R

[5] ARONSON DL, 83341 MIL LAB REF

[6] CARNELLI V, COMMUNICATION

[7] CARNELLI V, 1986, 17 INT C WORLD FED H

[8] ANALYSIS OF CYTOMEGALOVIRUS AND EPSTEIN-BARR VIRUS-ANTIBODY RESPONSES IN TREATED HEMOPHILIACS - IMPLICATIONS FOR THE STUDY OF ACQUIRED IMMUNE-DEFICIENCY SYNDROME [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 252 (01): : 83 - 85

[9] COLOMBO M, 1985, LANCET, V2, P1

[10] EIBL H, COMMUNICATION